Teriparatide increases bone mineral density in a man with osteoporosis pseudoglioma

Three Years Follow-up of Pamidronate Therapy in Two Brothers with Osteoporosis-Pseudoglioma Syndrome (OPPG) Carrying an LRP5 Mutation

(2011) E.R. Barros et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Genetic Analysis of Lrp5 Function in Osteoblast Progenitors

(2010) Vijay K. Yadav et al.   CALCIFIED TISSUE INTERNATIONAL

Therapy of hypoparathyroidism with intact parathyroid hormone

(2010) M. R. Rubin et al.   OSTEOPOROSIS INTERNATIONAL

Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis

(2009) Benjamin Z. Leder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Osteoporosis-pseudoglioma syndrome: Description of 9 new cases and beneficial response to bisphosphonates

(2008) Elizabeth A. Streeten et al.   BONE

Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum

(2008) Vijay K. Yadav et al.   CELL

Retreatment With Teriparatide One Year After the First Teriparatide Course in Patients on Continued Long-Term Alendronate

(2008) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate

(2008) Paul D. Miller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM